Search

everythinglearnresearchcommunity

for

Search:↓

Researchers developed promising agents for prostate cancer imaging, with the best one showing high potential for clinical use.

CCT128930 is a promising new drug that effectively targets and inhibits a cancer-related protein, showing potential for cancer treatment.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

The enzyme steroid sulfatase is linked to breast cancer and other conditions, and inhibitors are being developed for treatment.

New drugs targeting DNA enzymes show promise for cancer treatment but have side effects like immune system suppression and hair loss.

Stem cell therapies show promise for treating various diseases but face challenges in clinical use and require better monitoring techniques.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

The nano-carrier makes etoposide safer and more effective against lung cancer.

SARMs may be an effective treatment for a certain type of breast cancer by blocking cancer growth and spread.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

MK-2206 was safe and effectively blocked AKT signaling in cancer patients, warranting more trials.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Adding a second method to PROTACs could improve cancer treatment.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Prostate cancer cells can make their own androgens to activate the androgen receptor, and treatments like abiraterone may increase this ability, suggesting new therapies should target the entire steroid-making pathway.

Epirubicin is as effective as doxorubicin for cancer treatment with less heart damage, but doesn't work on doxorubicin-resistant cancers.

Alisertib was found to be an effective and tolerable treatment for children with recurrent brain tumors.

Certain herbal compounds, especially from bitter melon, can inhibit cancer growth and promote hair growth by blocking PAK1.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Dehydroepiandrosterone (DHEA) is a prohormone important for producing sex steroids and has potential health benefits.

The conclusion is that using drugs to block the TOR pathway might slow aging and prevent age-related diseases.

Eph receptors and ephrins may be promising targets for treating diseases, but more understanding is needed for effective and safe therapies.

The PDGF/PDGFR pathway is a potential drug target with mixed success in treating various diseases, including some cancers and fibrosis.

Steroid sex hormones activate matriptase in prostate cancer cells but not in breast cancer cells.

Certain drugs that block specific enzymes can help treat prostate diseases.

Nanoparticulate systems improve drug delivery by controlling release, protecting drugs, changing absorption and distribution, and concentrating drugs in targeted areas.

*Acorus calamus* has many medicinal benefits but needs more safety research.

Vitamin C helps adipose-derived stem cells grow and may support hair growth.

Drug repurposing is a cost-effective way to find new uses for existing drugs, speeding up treatment development.